Compliant Selection and Documentation Management of PCR Kits in Research and In Vitro Diagnostic Settings

First, clarify the intended use scenario: research or diagnostics.

PCR/qPCR kits play different roles in basic research, product development, and clinical testing. Research-use kits are typically used for gene expression analysis, genotyping, preliminary pathogen screening research, and similar applications, and are not directly intended for clinical diagnostic decision-making; whereas kits used in in vitro diagnostic settings must comply with relevant regulatory and registration requirements. Before procurement, laboratories should clarify the intended use of the kit and avoid using reagents labeled only for research use to issue diagnostic reports. For clinical or third-party testing laboratories, it is also necessary to confirm, in light of local regulatory requirements, whether the kit has the corresponding filing or registration information.

Qualification and technical documentation should be reviewed before procurement.

When selecting PCR/qPCR kits, in addition to amplification performance, attention should also be paid to whether the supplier can provide complete technical documentation and quality credentials. Common materials include product instructions, analytical performance specifications, storage and transport conditions, batch quality control reports, and safety data sheets. For kits involving pathogen detection, it should be confirmed whether their intended detection targets and applicable sample types match the laboratory's projects. If used for methodology development or research publication, it is advisable to retain the quality verification documentation provided by the supplier so that the source of reagents and basis for performance can be explained during peer review or audit. Procurement decisions should never be made based solely on promotional page information.

Basic content of in-house laboratory performance verification.

Regardless of which PCR/qPCR kit is used, laboratories should generally complete the necessary performance confirmation before formal use. Verification content may include: linear range and amplification efficiency at different template concentrations, repeatability (intra-assay and inter-assay), analytical specificity (using closely related or common interfering samples), preliminary assessment of the limit of detection, and so on. Specific parameters should be set according to project risk and application purpose, and it is not advisable to directly copy the manufacturer's data. The verification process should be documented, stating the sample types used, nucleic acid extraction method, reaction conditions, and result interpretation criteria. If reagent lots are subsequently changed or key steps are adjusted, the impact on results should be reassessed.

Common requirements for records and document retention.

Standardized record management is the basis for ensuring the traceability of PCR/qPCR kit use. It is recommended to record information such as kit name, catalog number, lot number, expiration date, opening date, storage temperature, and personnel using it; experimental records should also include the reaction system, program, instrument status, and raw data files. For important projects, amplification curves, Ct values, and screenshots of result interpretation should also be retained. The document retention period may be determined according to the laboratory's quality system requirements, but should generally cover the project cycle and possible data review stages. Good records not only help troubleshoot abnormal results, but also provide support during external quality assessment or on-site audits.

Points to note in supplier communication.

When unexpected results occur with PCR/qPCR kits, timely communication with the supplier helps identify the problem. Before communicating, batch information, storage records, reaction setup, and representative graphs should be organized, avoiding reliance solely on subjective judgment. You may ask whether there have been formulation adjustments, packaging changes, or abnormal transport temperatures. For recurring problems, it is advisable to request a written explanation from the supplier or compare with an alternative lot. By establishing a stable supplier evaluation and feedback mechanism, laboratories can continuously optimize reagent use strategies and reduce experimental failures or data deviations caused by reagent variability.